• Je něco špatně v tomto záznamu ?

Neurobiology and therapeutic applications of neurotoxins targeting transmitter release

SV. Ovsepian, VB. O'Leary, NM. Ayvazyan, A. Al-Sabi, V. Ntziachristos, JO. Dolly,

. 2019 ; 193 (-) : 135-155. [pub] 20180825

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006793

Synaptic transmission is a fundamental neurobiological process enabling exchange of signals between neurons as well as neurons and their non-neuronal effectors. The complex molecular machinery of the synaptic vesicle cycle and transmitter release has emerged and developed in the course of the evolutionary race, to ensure adaptive gain and survival of the fittest. In parallel, a generous arsenal of biomolecules and neuroactive peptides have co-evolved, which selectively target the transmitter release machinery, with the aim of subduing natural rivals or neutralizing prey. With advances in neuropharmacology and quantitative biology, neurotoxins targeting presynaptic mechanisms have attracted major interest, revealing considerable potential as carriers of molecular cargo and probes for meddling synaptic transmission mechanisms for research and medical benefit. In this review, we investigate and discuss key facets employed by the most prominent bacterial and animal toxins targeting the presynaptic secretory machinery. We explore the cellular basis and molecular grounds for their tremendous potency and selectivity, with effects on a wide range of neural functions. Finally, we consider the emerging preclinical and clinical data advocating the use of active ingredients of neurotoxins for the advancement of molecular medicine and development of restorative therapies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006793
003      
CZ-PrNML
005      
20200527095439.0
007      
ta
008      
200511s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.pharmthera.2018.08.016 $2 doi
035    __
$a (PubMed)30149105
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Ovsepian, Saak V $u Institute for Biological and Medical Imaging, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Neuherberg, Germany; Munich School of Bioengineering, Technical University Munich, Munich, Germany; International Centre for Neurotherapeutics, Dublin City University, Dublin, Ireland; The National Institute of Mental Health, Topolová 748, Klecany, Czechia; Faculty of Medicine at Charles University, Prague, Czechia. Electronic address: saak.ovsepian@gmail.com.
245    10
$a Neurobiology and therapeutic applications of neurotoxins targeting transmitter release / $c SV. Ovsepian, VB. O'Leary, NM. Ayvazyan, A. Al-Sabi, V. Ntziachristos, JO. Dolly,
520    9_
$a Synaptic transmission is a fundamental neurobiological process enabling exchange of signals between neurons as well as neurons and their non-neuronal effectors. The complex molecular machinery of the synaptic vesicle cycle and transmitter release has emerged and developed in the course of the evolutionary race, to ensure adaptive gain and survival of the fittest. In parallel, a generous arsenal of biomolecules and neuroactive peptides have co-evolved, which selectively target the transmitter release machinery, with the aim of subduing natural rivals or neutralizing prey. With advances in neuropharmacology and quantitative biology, neurotoxins targeting presynaptic mechanisms have attracted major interest, revealing considerable potential as carriers of molecular cargo and probes for meddling synaptic transmission mechanisms for research and medical benefit. In this review, we investigate and discuss key facets employed by the most prominent bacterial and animal toxins targeting the presynaptic secretory machinery. We explore the cellular basis and molecular grounds for their tremendous potency and selectivity, with effects on a wide range of neural functions. Finally, we consider the emerging preclinical and clinical data advocating the use of active ingredients of neurotoxins for the advancement of molecular medicine and development of restorative therapies.
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    _2
$a neurotoxiny $x toxicita $7 D009498
650    _2
$a neurotransmiterové látky $x metabolismus $7 D018377
650    _2
$a nervový přenos $x účinky léků $7 D009435
650    _2
$a biologické toxiny $x toxicita $7 D014118
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a O'Leary, Valerie B $u International Centre for Neurotherapeutics, Dublin City University, Dublin, Ireland.
700    1_
$a Ayvazyan, Naira M $u Orbeli Institute of Physiology, National Academy of Sciences of the Republic of Armenia, Yerevan, Armenia.
700    1_
$a Al-Sabi, Ahmed $u College of Engineering and Technology, American University of the Middle East, Eqaila, Kuwait.
700    1_
$a Ntziachristos, Vasilis $u Institute for Biological and Medical Imaging, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Neuherberg, Germany; Munich School of Bioengineering, Technical University Munich, Munich, Germany.
700    1_
$a Dolly, James O $u International Centre for Neurotherapeutics, Dublin City University, Dublin, Ireland. Electronic address: oliver.dolly@dcu.ie.
773    0_
$w MED00006662 $t Pharmacology & therapeutics $x 1879-016X $g Roč. 193, č. - (2019), s. 135-155
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30149105 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200527095436 $b ABA008
999    __
$a ok $b bmc $g 1525651 $s 1096849
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 193 $c - $d 135-155 $e 20180825 $i 1879-016X $m Pharmacology & therapeutics $n Pharmacol Ther $x MED00006662
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace